Amarin Corporation plc AMRN reported an adjusted loss of 5 cents per share for the third quarter of 2024, which was in line with the Zacks Consensus Estimate. The company had reported breakeven earnings...
AMRN earnings call for the period ending September 30, 2024.
AMRN earnings call for the period ending June 30, 2024.
AMRN earnings call for the period ending March 31, 2024.
/CNW/ - HLS Therapeutics Inc. (HLS or the Company) (TSX: HLS), a pharmaceutical company focusing on addressing unmet needs in the treatment of psychiatric...
There was unambigously good news about the company's single commercialized medication.
AMRN earnings call for the period ending December 31, 2023.
The biopharma company announced a big repurchase plan, along with strong preliminary Q4 results.